Knockdown of KRAS in pancreatic cancer cell lines leads to decreased motility and proliferation. The Grb2–Sos1 complex may promote cell motility, and tumerogenesis (Qu et al., 2014). This evidence concerns the gene GRB2 and familial pancreatic carcinoma.